Package 68788-7988-3

{"route": ["ORAL"], "spl_id": "c0d9bf32-c09b-4504-96da-6607fa11339c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687"], "spl_set_id": ["eabb54b7-164c-4de8-b91a-f2e65637b5fc"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (68788-7988-1)", "package_ndc": "68788-7988-1", "marketing_start_date": "20240311"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (68788-7988-3)", "package_ndc": "68788-7988-3", "marketing_start_date": "20210806"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (68788-7988-6)", "package_ndc": "68788-7988-6", "marketing_start_date": "20210806"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (68788-7988-9)", "package_ndc": "68788-7988-9", "marketing_start_date": "20210806"}], "brand_name": "Bupropion Hydrochloride", "product_id": "68788-7988_c0d9bf32-c09b-4504-96da-6607fa11339c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-7988", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA076143", "marketing_category": "ANDA", "marketing_start_date": "20210806", "listing_expiration_date": "20261231"}